article thumbnail

AZmed’s AZchest Receives Two FDA Clearances for AI-Powered Software Applications

XTalks

European AI med tech company AZmed received two new FDA clearances for its AI-powered chest X-ray tool, AZchest. The FDA approved AZchest applications to detect lung nodules and triage cases involving pneumothorax and pleural effusion. The company rebranded the name of its AI suite from Rayvolve to AZchest.

article thumbnail

FDA Approves Siemens Photon-Counting CT Scanner as First CT Upgrade in a Decade

XTalks

CT imaging is a key non-invasive medical tool used in the diagnosis and monitoring of disease and injury. With no major innovations in the field for nearly a decade, the new photon-scanning technology may transform CT imaging by making it more detailed and efficient by drastically improving image quality.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves First Over-the-Counter Fully At-Home Test for COVID-19

The Pharma Data

FDA Approves First Over-the-Counter Fully At-Home Test for COVID-19. Last week, the FDA approved a different at-home test, but it requires samples to be mailed to a lab to get the results. Professional. TUESDAY, Dec. Food and Drug Administration. Results are delivered by smartphone in as little as 20 minutes.

article thumbnail

New Diagnostic Drug Flyrcado Enhances Coronary Artery Disease Diagnosis

XTalks

GE HealthCare’s newly US Food and Drug Administration (FDA)- approved flurpiridaz F 18 positron emission tomography (PET) radiotracer, Flyrcado, could offer a new approach to diagnosing coronary artery disease (CAD). These products exemplify the company’s ongoing efforts to advance molecular imaging.

article thumbnail

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19

The Pharma Data

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. The speed and rigor with which Veklury has been developed and approved in the U.S.

article thumbnail

14th Asia Pacific Symposium on Cochlear Implant and Related Sciences Set to Convene in Seoul — Featuring HP&M’s Dr. Philip Won

FDA Law Blog

Won will share his expertise and insights on the intricacies of the United States Food and Drug Administration (FDA) regulations pertaining to medical devices, with a special focus on class II and class III hearing devices. The comprehensive agenda for the symposium can be accessed in its entirety here.

article thumbnail

How IpsiHand Can Help Stroke Patients Regain Movement through Neurological Rehabilitation

XTalks

With the authorization, the IpsiHand System becomes the first non-invasive neurological rehabilitation device to receive FDA approval in the rapidly growing brain-computer interface space.

Radiology 105